Eli Lilly and Company
This role involves developing chemistry for scalable and environmentally friendly manufacturing processes within the Synthetic Molecule Design and Development organization, supporting the Lilly Genetic Medicines portfolio. The scientist will collaborate with internal and external teams to optimize synthetic methods, lead CMC activities for clinical trials, and manage tech transfer for oligonucleotide therapeutics. The position requires expertise in oligonucleotide CMC, process development, and regulatory submissions to bring life-changing medicines to patients.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
47% above the average for this role
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Process Discovery Chemist
GSK plc
Senior Scientist - Synthetic Chemist in Oligonucleotide Therapeutics
AstraZeneca
Principal Scientist I or II, Oligonucleotide Chemistry and Innovation
Novartis
Director, CMC – Small Molecule Chemistry
Pathos
Associate Director, CMC Synthetic Chemistry – Small Molecule
Beeline Medicines
Senior Scientist Synthetic Chemist In Oligonucleotide Therapeutics M%C3%B6lndal Sweden
AstraZeneca